Knowles Co. (NYSE:KN – Get Free Report) Director Cheryl L. Shavers sold 12,579 shares of the firm’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of $17.29, for a total transaction of $217,490.91. Following the sale, the director now owns 48,933 shares of the company’s stock, valued at $846,051.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Knowles Trading Up 2.0 %
KN traded up $0.34 on Tuesday, hitting $17.56. The company had a trading volume of 851,824 shares, compared to its average volume of 577,189. The company’s fifty day moving average price is $17.74 and its 200 day moving average price is $17.07. Knowles Co. has a 1 year low of $12.78 and a 1 year high of $19.73. The company has a current ratio of 2.36, a quick ratio of 1.30 and a debt-to-equity ratio of 0.28. The firm has a market cap of $1.58 billion, a P/E ratio of 19.55 and a beta of 1.42.
Knowles (NYSE:KN – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The communications equipment provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.16). Knowles had a positive return on equity of 5.39% and a negative net margin of 24.36%. The company had revenue of $204.70 million during the quarter.
Institutional Investors Weigh In On Knowles
Analyst Upgrades and Downgrades
Separately, Susquehanna increased their price target on shares of Knowles from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, July 17th.
Read Our Latest Report on Knowles
Knowles Company Profile
Knowles Corporation offers capacitors, radio frequency (RF) filtering products, balanced armature speakers, micro-acoustic microphones, and audio solutions in Asia, the United States, Europe, other Americas, and internationally. It operates through three segments: Precision Devices (PD); Medtech & Specialty Audio (MSA); and Consumer MEMS Microphones (CMM).
Featured Articles
- Five stocks we like better than Knowles
- How to Invest in the Best Canadian Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Trending Stocks? Trending Stocks Explained
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Use Stock Screeners to Find Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Knowles Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knowles and related companies with MarketBeat.com's FREE daily email newsletter.